title: Increased proliferative activity, loss of beta-adrenergic receptor function and class I major histocompatibility complex antigen surface expression in a modified lymphoma cell line.
abstract: The molecular interaction of class I major histocompatibility complex (MHC) antigens (Ag) and of beta-adrenergic receptors was previously demonstrated on lymphocytes. By long-term culturing with high concentration of foetal calf serum, the murine S49 lymphoma cell line was modified (S49m) giving phenotypic alterations in beta-adrenergic receptors and class I Ag expression. S49m cells displayed a reduced number of beta-adrenergic sites that were uncoupled to the adenylate cyclase system. These were unable to respond to beta agonist stimulation, despite the fact that direct activation of Gs could be achieved with aluminium tetrafluoride. Although S49m cells showed normal expression of the thy 1.2 Ag, they displayed no expression of class I Ag of the d haplotype. This was assessed by the evident lack of cytotoxic activity of specific monoclonal antibodies (Mo Ab) and of their binding. When performing IFI staining on permeabilized cells, we found positive staining with anti-class d Ab inside the cell. This loss of expression and activity of beta-adrenoceptors and the internalization of class I Ag were accompanied by a higher rate of proliferation in S49m cells. The possibility that the loss of both molecules would modify the biology of the cell is also discussed.
authors.affiliation: Centro de Estudios Farmacológicos y Botánicos (CEFYBO), CONICET, Buenos Aires, Argentina.
authors.forename: G A
authors.initials: GA
authors.lastname: Cremaschi
authors.forename: S
authors.initials: S
authors.lastname: Miguel
authors.forename: C
authors.initials: C
authors.lastname: Cazaux
authors.forename: L
authors.initials: L
authors.lastname: Sterin-Borda
mesh_terms: D000319:Adrenergic beta-Antagonists; D000818:Animals; D015415:Biomarkers; D002455:Cell Division; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D008223:Lymphoma; D051379:Mice; D010869:Pindolol / Q000031:analogs & derivatives; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D000319:Adrenergic beta-Antagonists; D015415:Biomarkers; D015395:Histocompatibility Antigens Class I; D011943:Receptors, Adrenergic, beta; C047975:cyanopindolol; D010869:Pindolol